We became core members of a European innovation grant devoted to test cardioprotective strategies, partners of a multicentric international preclinical platform (IMproving Preclinical Assessment Cardioprotective Therapies). Since 2022, we’re part of a public-private consortium devoted to investigate p38 MAPK inhibitors as novel drugs for cardioprotection in ischemia-reperfusion and chemotherpay (PLEC2022-009227 Ministry Science). We have received a grant of ISCIII to investigate the contribution of cell senescence to heart dysfunction during aging. We’ve got the coordination of a WP within an important international collaboration H2020 (DataTool4heart), we’re started leading an important project regarding Retaining-Artificial intelligence for an affordable early diagnosis of heart diseases via cardiac tissue characterization on echocardiography images. We got an excellent SGR evaluation as “Grup consolidat Malalties cardiovasculars”. More than 30 articles have been published.

Group Leader
Ignacio Ferreira González

Principal Investigator (PI)
José Antonio Barrabés Riu, Jordi Bañeras, Neus Bellera, Begoña Benito Villabriga, Laura Dos Subirá, Arturo Evangelista Masip, Bruno García Del Blanco, Javier Inserte Igual, Aida Ribera Sole, Nuria Rivas Gandara, José F Rodríguez Palomares, Antonio Rodríguez Sinovas, Marisol Ruiz Meana, Antonia Sambola Ayala, Gisela Teixidó, Andrea Guala, Antonia Pijuan Domènech

Researchers
Laura Galián Gay, Jordi Pérez Rodón, Nazarena Pizzi María, David Aluja González, Mireia Andrés, Lidia Dux Santoy, Laia Yañez, Diana Bou Teen, Aitor Uribarri, Ana Méndez, Alvaro Calabuig, Jordi Lozano, Raquel Adeliño, Jaume Francisco Pascual, Eduard Ródenas, Irene Buera, Guillem Casas Masnou, Rubén Fernández Galera, Blanca Gordon, Laura Gutiérrez García-Moreno, Javier Limeres Freire, Gerard Martí Aguasca, Laia Milà Pascual, Berta Miranda Barrio, Gerard Oristrell Santamaria, Imanol Otaegui Irurueta, Alba Santos Ortega, Bernat Serra Creus, Vicenç Serra García, Luz Servato, Filipa Valente, Pau Rello Sabaté, Toni Soriano, Yasim Belahnech Pujol, Alex Olivella, Javier Cantalapiedra

PhD Students
Marta Consegal Pérez, Sara Delgado Tomás, Aroa Ruiz Muñoz, Freddy Ganse

Lab Technicians
Ángeles Rojas López

Nursing and Technical Staff
Raul Aguilar López, Mª Angeles Carmona Ramírez, Elisabeth Miró Casas, Claudia Álvarez, Marta Alvarez, Irene Montllor, Emma Pasto, Andrea Lorite

139

PUBLICATIONS

61.9%

%Q1

1,745

IMPACT FACTOR

12.56

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

Evangelista A, Pineda V, Guala A, Bijnens B, Cuellar H, Rudenick P, Sao-Aviles A, Ruiz A, Teixido-Tura G, Rodriguez-Lecoq R, Bellmunt S, Ferreira I, Rodríguez-Palomares J
False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection
J Am Coll Cardiol. 2022 Jun 21;79(24):2415-2427
DOI: doi: 10.1016/j.jacc.2022.04.017.
IF: 27.203

Guala A, Dux-Santoy L, Teixido-Tura G, Ruiz-Muñoz A, Galian-Gay L, Servato ML, Valente F, Gutiérrez L, González-Alujas T, Johnson KM, Wieben O, Casas-Masnou G, Sao Avilés A, Fernandez-Galera R, Ferreira-Gonzalez I, Evangelista A, Rodríguez-Palomares JF
Wall Shear Stress Predicts Aortic Dilation in Patients With Bicuspid Aortic Valve
JACC cadiovasc imag. 2022 Jan;15(1):46-56
DOI: doi: 10.1016/j.jcmg.2021.09.023
IF: 16.051

Bou-Teen D, Fernandez-Sanz C, Miro-Casas E, Nichtova Z, Bonzon-Kulichenko E, Casós K, Inserte J, Rodriguez-Sinovas A, Benito B, Sheu SS, Vázquez J, Ferreira-González I, Ruiz-Meana M
Defective dimerization of FoF1-ATP synthase secondary to glycation favors mitochondrial energy deficiency in cardiomyocytes during aging
Aging Cell. 2022 Mar;21(3):e13564
DOI: doi: 10.1111/acel.13564
IF: 11.005

Ruiz-Muñoz A, Guala A, Rodriguez-Palomares J, Dux-Santoy L, Servato L, Lopez-Sainz A, La Mura L, Granato C, Limeres J, Gonzalez-Alujas T, Galián-Gay L, Gutiérrez L, Johnson K, Wieben O, Sao-Aviles A, Ferreira-Gonzalez I, Evangelista A, Teixido-Tura G
Aortic flow dynamics and stiffness in Loeys-Dietz syndrome patients: a comparison with healthy volunteers and Marfan syndrome patients.
Eur Heart J Cardiovasc Imaging. 2022 Apr 18;23(5):641-649
DOI: doi: 10.1093/ehjci/jeab069
IF: 9.130

Ródenas-Alesina E, Romero-Farina G, Jordán P, Herrador L, Espinet-Coll C, Pizzi MN, Ribera A, Barrabés JA, Aguadé-Bruix S, Ferreira-González I
Impact of revascularization guided by functional testing in ischaemic cardiomyopathy
Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):1304-1311
DOI: doi: 10.1093/ehjci/jeac125
IF: 9.130

A European Health Data Toolbox for Enhancing Cardiology Data Interoperability, Reusability and Privacy
Principal Investigator: PI Spain: JF Rodríguez Palomares -PI internacional: Karim Lekadir
Agency: European Commission (Horizon Europe)-
Funding: 322,500€
Period: 2022-2026

Retaining-Artificial intelligence for an affordable early diagnosis of heart diseases via cardiac tissue characterization on echocardiography images.
Principal Investigator: Andrea Guala
Agency: Fundació La Caixa
Funding: 292,500€
Period: 2022-2025

ADAIR: Advances in Diagnosis and Prognosis of Atherosclerosis for High Risk Diabetic Patients.
Principal Investigator: JF Rodríguez Palomares -CO-IP A Guala
Agency: Ministerio de Ciencia e Innovación
Funding: 224,860€
Period: 2022-2024

TARTAGLIA Federated Network to Accelerate the Application of Artificial Intelligence In The Spanish Health System (TARTAGLIA)
Principal Investigator: JF Rodríguez Palomares
Agency: Ministerio de Asuntos Económicos y Transformación Digital
Funding: 166,956€
Period: 2022-2024

Artificial intelligence for an affordable early diagnosis of heart diseases via cardiac tissue characterisation on echocardiography images (CHEAP-HEART)
Principal Investigator: Andrea Guala
Agency: Ministerio de Ciencia e Innovación
Funding: 152,460€
Period: 2022-2025

eCOREs